- Home
- WETH vs IMRN Comparison
WETH vs IMRN Comparison
Compare WETH & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- IMRN
- Stock Information
- Founded
- WETH 1992
- IMRN 1994
- Country
- WETH China
- IMRN Australia
- Employees
- WETH N/A
- IMRN N/A
- Industry
- WETH
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WETH
- IMRN Health Care
- Exchange
- WETH Nasdaq
- IMRN Nasdaq
- Market Cap
- WETH 10.9M
- IMRN 14.4M
- IPO Year
- WETH N/A
- IMRN N/A
- Fundamental
- Price
- WETH $2.18
- IMRN $2.15
- Analyst Decision
- WETH
- IMRN
- Analyst Count
- WETH 0
- IMRN 0
- Target Price
- WETH N/A
- IMRN N/A
- AVG Volume (30 Days)
- WETH 320.3K
- IMRN 94.3K
- Earning Date
- WETH 10-09-2025
- IMRN 08-29-2025
- Dividend Yield
- WETH N/A
- IMRN N/A
- EPS Growth
- WETH 63.71
- IMRN N/A
- EPS
- WETH 0.63
- IMRN N/A
- Revenue
- WETH $42,877,572.00
- IMRN $4,777,422.00
- Revenue This Year
- WETH N/A
- IMRN N/A
- Revenue Next Year
- WETH N/A
- IMRN N/A
- P/E Ratio
- WETH $3.47
- IMRN N/A
- Revenue Growth
- WETH 5.58
- IMRN 48.63
- 52 Week Low
- WETH $0.76
- IMRN $1.50
- 52 Week High
- WETH $2.41
- IMRN $2.48
- Technical
- Relative Strength Index (RSI)
- WETH 76.22
- IMRN 55.04
- Support Level
- WETH $1.65
- IMRN $2.06
- Resistance Level
- WETH $1.89
- IMRN $2.25
- Average True Range (ATR)
- WETH 0.24
- IMRN 0.14
- MACD
- WETH 0.05
- IMRN -0.01
- Stochastic Oscillator
- WETH 81.20
- IMRN 42.50
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.